Weiss Multi-Strategy Advisers’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-12,500
Closed -$2.49M – 720
2023
Q3
$2.49M Sell
12,500
-6,926
-36% -$1.64M 0.06% 349
2023
Q2
$5.54M Buy
19,426
+13,039
+204% +$3.62M 0.11% 261
2023
Q1
$1.38M Buy
6,387
+1,987
+45% +$387K 0.03% 476
2022
Q4
$905K Buy
4,400
+2,700
+159% +$683K 0.03% 469
2022
Q3
$473K Buy
1,700
+400
+31% +$102K 0.01% 557
2022
Q2
$249K Buy
+1,300
New +$229K 0.01% 601
2020
Q1
– Sell
-5,000
Closed -$220K – 657
2019
Q4
$220K Buy
+5,000
New +$185K ﹤0.01% 571

Other funds holding SWAV

Weiss Multi-Strategy Advisers's SWAV Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Shockwave Medical (SWAV) in Q4 2023, closing a stake of 12,500 shares — an estimated $2.49M sold.

Weiss Multi-Strategy Advisers first reported a position in SWAV in Q4 2019 and held it in 7 quarters. The position peaked at $5.54M in Q2 2023. 425 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Shockwave Medical position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 12,500 Shockwave Medical shares in Q4 2023, an estimated $2.49M.
  • Weiss Multi-Strategy Advisers first reported a position in Shockwave Medical in Q4 2019 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Shockwave Medical position peaked at $5.54M in Q2 2023.
  • 425 funds tracked by Wall St. Rank held Shockwave Medical as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.